217 related articles for article (PubMed ID: 2639729)
1. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
[TBL] [Abstract][Full Text] [Related]
2. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
[TBL] [Abstract][Full Text] [Related]
4. Tiazofurin induction of mouse erythroleukemia cell hemoglobin production in the absence of commitment or changes in protooncogene expression.
Sherman ML; Shafman TD; Colman MS; Kufe DW
Blood; 1989 Feb; 73(2):431-4. PubMed ID: 2917182
[TBL] [Abstract][Full Text] [Related]
5. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
[TBL] [Abstract][Full Text] [Related]
8. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP
Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352
[TBL] [Abstract][Full Text] [Related]
9. Tiazofurin decreases Ras-GTP complex in K562 cells.
Hata Y; Natsumeda Y; Weber G
Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
[TBL] [Abstract][Full Text] [Related]
10. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
11. cAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression.
Kuroyanagi Y; Kaneko Y; Muta K; Park BS; Moi P; Ausenda S; Cappellini MD; Ikuta T
Biochem Biophys Res Commun; 2006 Jun; 344(3):1038-47. PubMed ID: 16631597
[TBL] [Abstract][Full Text] [Related]
12. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
Vitale M; Zamai L; Falcieri E; Zauli G; Gobbi P; Santi S; Cinti C; Weber G
Cytometry; 1997 Feb; 30(1):61-6. PubMed ID: 9056744
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
Mitchell T; Sariban E; Kufe D
Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
[TBL] [Abstract][Full Text] [Related]
15. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
16. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
18. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
Saunders PP; Kuttan R; Lai MM; Robins RK
Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
[TBL] [Abstract][Full Text] [Related]
20. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
